First of all I am very sorry to keep posting wrong view of all the media ,writers and analysists, not to mention fund managers.
Please have a look this video posted on sydney monening herold few minutes ago.
China's crackdown stings Blackmores, a2, Bellamy's
http://www.smh.com.au/video/video-b...gs-blackmores-a2-bellamys-20160415-4djf7.html
Why Putting chinese labelling will reduce demand of a2 platinum?
Can anyone tell me?
Before u tell me , I will show u something first.
Many of u familliar with the south korean milk company MaeIl's huge success in China.
80 fold revenue increase in 5 years.
2011 revenue : $6.1 M
2015 revenue : $477M
Now question.
In order to have that huge success in china
Do u think MaeIl company put korean labelling on the tins?
NoNoNoNo!!!!!
Chinese wnated to read the whats on the ti n, ingredients and infomation.
This is MaeIl infant formula in Korea
Of course Korean language
This is MaeIl infant formula on the market.
Look closely if this is same language as above.
This is chinese language!!
Selling on the shelves in China.
Then how come they achieved 80 fold revenue increase?
Why that guy is spreading wrong info and image , misleading all the people with that comments?
Based on what evidence?
Please tell me..
I am really sick of these stupid people.
Shouldnt they have some study and research before do big comments on tv?
They should research other companys performance with chinese labelling shouldnt it? How it afftects the revenue..
I am telling the truth with evidence now.
I want to hear what made him say that bull shiiits.
- Forums
- ASX - By Stock
- A2M
- Very stupid and no brain fund managers and analysists
Very stupid and no brain fund managers and analysists
-
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add A2M (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.85 |
Change
-0.030(0.44%) |
Mkt cap ! $4.959B |
Open | High | Low | Value | Volume |
$6.93 | $6.98 | $6.83 | $7.692M | 1.113M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 4364 | $6.85 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.86 | 20209 | 35 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 1365 | 6.850 |
21 | 32182 | 6.840 |
17 | 40911 | 6.830 |
8 | 11242 | 6.820 |
11 | 79798 | 6.810 |
Price($) | Vol. | No. |
---|---|---|
6.860 | 16573 | 36 |
6.870 | 18833 | 21 |
6.880 | 36014 | 18 |
6.890 | 31413 | 12 |
6.900 | 38481 | 15 |
Last trade - 15.22pm 15/07/2024 (20 minute delay) ? |
Featured News
A2M (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online